From the earliest available descriptions of episcleritis (Slade, 1838; Rognetta, i844; Desmarres, 1847) a confusion has existed between scleritis and episcleritis. This has led to contradictory views on the relative severity and prognosis of these conditions, and the erroneous belief that episcleritis is accompanied by serious complications (Viswalingham, 1936; Wood, 1936; Mann and Markson, I950; Clavel and Teulieres, 1958) . While Slade (I838), Rognetta (i844), and Desmarres (I847), thought that episcleritis was both common and severe, Mackenzie (i 830) considered it to be neither and gave at the same time a vivid and accurate description of scleritis. This confusion still persists today.
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In an attempt to clarify the position we have been studying patients with scleritis and episcleritis in a special clinic at Moorfields Eye Hospital during the past io years. Of these, 207 patients (30I eyes) with episcleritis and 159 patients (2I7 eyes) with scleritis were analysed in depth. § The results reported below have led us to conclude that scleritis and episcleritis are clinically distinct, with a different symptomatology and prognosis and requiring different management.
The incidence of these conditions is not known, but Williamson (1974) suggested that it was about o-o8 per cent of hospital new patient referrals. Our series is from highly selected patients, all being referred from elsewhere, often where there was difficulty in diagnosis, and with unusual problems. This is reflected in the fact that go per cent of the patients who had rheumatoid arthritis were seen within a year of the start of the special clinic. 
Material
Using the above classification, patients were distributed as in Table I. Normal anatomy Before considering the criteria by which the differential diagnosis is reached it is necessary to.
understand the normal vascular anatomy of the outer coats of the eye. The blood vessels of the episclera are not easily seen in the uninflamed eye, but as soon as the eye becomes congested three quite separate vascular plexuses become readily visible.
i. Bulbar conjunctival plexus (Fig. i) This is the most superficial plexus of fine hair-like interlacing vessels freely moveable over the underlying structures. Overlying the episclera the conjunctival arteries are derived from two sources the anterior ciliary arteries at the limbus, and the palpebral branches of the ophthalmic and lacrimal arteries. When they are inflamed the colour is bright red.
Episcleral plexus (Fig. i)
The vessels, which are straight and radially arranged, lie in the superficial episclera (parietal layer of Tenon's capsule) at a depth of about onequarter to one-third of the distance between the surface of the conjunctiva and sclera (Graves, 1937) . The visible vessels are mainly veins, accepting the aqueous veins at intervals around the globe. These vessels are moveable over the deep layers, although not so easily as the conjunctival vessels. In the anterior episcleral plexus (anterior to the equator and over the muscle) the vessels belong to the anterior ciliary system; while in the posterior episcleral arterial plexus (posterior to the equator) they are derived from the arteries of the oblique muscles, the posterior ciliary arteries, and the vessels of the optic nerve sheaths (Hayreh and Baines, 1972) . When inflamed, these radially arranged vessels can easily be seen, giving the eye a salmon pink colour.
3. Scleral (deep episcleral) plexus (Fig. I) This plexus consists of a rete (criss-cross) of vessels lying within the visceral layer of Tenon's capsule, closely applied to the sclera. At the limbus the superficial and deep episcleral plexuses merge into one another and terminate in the superficial marginal plexuses of the cornea. When congested this layer looks bluish-red in colour and is immobile.
Clinical examination Careful examination will determine the depth of the inflammation, so that it is almost always possible to decide when the patient is first seen whether scleritis or episcleritis is present. This depends on accurate observation of the relationship of one layer of vessels to the other and to the underlying sclera.
HISTORY
A detailed clinical history is taken of the patient's ocular and systemic disorders, including family history. Any contact with chemical irritants and solvents is noted, as is any history of allergic conditions, rheumatic, connective-tissue or skin disease, gout, venereal disease, tuberculosis, or sarcoidosis. The site, distribution, and nature of any ocular pain and disturbances of vision are important in deciding the type of inflammation present.
EXAMINATION OF THE EYE
After the visual acuity has been recorded, the following routine of examination is used:
I. External examination of the eye in daylight It is essential to examine a case of episcleritis in daylight as this is often the only way of distin- FIG. i Normal vascular networks of episclera. There are three layersthe-deepest is almost invisible in the guishing episcleritis from the much more serious scleral disease. In episcleritis the colour is salmon pink; in deep scleral disease the colour has a much deeper purple hue. These colour changes are difficult to distinguish in tungsten or fluorescent light. After recurrent attacks of scleral inflammation the sclera may become more transparent and is sometimes thinner, and as a consequence the grey choroid may be seen through the sclera. Sometimes these areas are black and well defined, but more often they give a faint grey tinge to the sclera. This is a particularly important observation in scleromalacia perforans, in which there is no surrounding inflammation. Time and again it is possible to see areas of scleral thinning in daylight which were invisible with the slit-lamp or by illumination with tungsten or fluorescent light.
2. Slit-lamp microscopic examination Of the greatest assistance in distinguishing episcleritis from scleritis is the relationship of one vascular network with another and the changes within them. The object of this examination is to confirm the macroscopic findings. In scleritis, the examination is directed to detecting scleral oedema and the involvement of scleral vessels, ignoring the fact that the overlying episclera will be congested and oedematous. In episcleritis there will be no oedema of the sclera. In 
Results

PATIENTS
The data were derived from 207 patients (30I eyes) with scleritis and 159 patients (2I7 eyes) with episcleritis (Table I) i. Scieritis
Analysis of the age and sex distribution for the different types of scleritis revealed distinct patterns for each type of scleritis. The diffuse and nodular varieties were most prevalent. In men the peak incidence occurred in the fourth decade (P= < o05); women showed two separate peak incidences, one in the third decade and another in the sixth decade (P= < o0o5).
Scleritis-diffuse anterior scleritis
In women the disease was commonest in the fourth to seventh decades, with no predilection for any age group. In men it was more prevalent in the third to sixth decades, with a distinct peak during the fourth. The condition was rare in the young and the old.
Scleritis-nodular anterior scleritis
The nodular disease in both sexes was most prevalent from the fourth to sixth decades, but in women there was a very marked peak during the sixth decade.
Scleritis-necrotizing type with inflammation Of the patients who presented with this severe variety of scleritis the majority were women, but of those who presented during the fourth decade all but one were men.
Scleritis-necrotizing type without inflammation (scleromalacia perforans) All these patients were women. The age range was 35 to 75 years, most cases occurring in the fifth decade.
Scleritis-posterior scleritis
Posterior scleritis was usually associated with a diffuse anterior scleritis, occurring most frequently in women in their sixth decade, but one woman of 35 years was seen with this condition.
Episcleritis
Altogether 88 men and 71 women suffered from episcleritis. There was a significant variation in the sex distribution at different ages. The condition was not seen in childhood. Episcleritis in men occurred maximally from the third to the sixth decade, with a peak in the fourth decade. In women, however, although there was a peak incidence in the fourth and fifth decades, the distribution did not show a predilection for any particular age group. The difference between the peak incidence in the different series was highly significant (P= < o005). There was no significant difference in the sexes between the time of onset of simple and nodular episcleritis, but nodular episcleritis had a peak incidence in the fifth decade whereas simple episcleritis was most common in the fourth decade (P= <o0o5). The essential diagnostic feature in scleritis was the involvement of scleral tissue in the inflammatory process. This usually took the form of scleral oedema which could be detected by observing the outward displacement of the deep vascular network of the episclera (Fig. 2) .
Because the episclera was always swollen and congested in scleritis, scleral oedema was the sign which had to be looked for. The deep episcleral vascular plexus was more congested than the superficial network, giving rise to the typical bluish-red colour. The conjunctival vessels were rarely involved.
SCLERITIS-NODULAR ANTERIOR SCLERITIS (Fig. 3) Although these patients resembled those with nodular episcleritis on cursory examination, detailed examination revealed marked differences and rarely presented any difficulty in diagnosis. The nodule was deep red in colour, totally immobile and quite separate from the overlying congested episcleral tissues. All the vessels were lifted by the nodule. There was, of course, some secondary overlying episcleritis and conjunctival congestion which involved the whole anterior episclera in 20 per cent (Fig. 3) . Multiple nodules were seen in 42 per cent, sometimes reaching an enormous size; in 50 per cent they were tender. (Fig. 4) This was the most benign form of scleritis and it was associated with the least severe of the associated general conditions. The patients might present with an eye in which the sclera was obscured by a diffuse redness and swollen episclera, which might be accompanied in severe cases by conjunctival oedema so severe as to obscure the cornea and protrude from between the eyelids. In these patients adrenaline i :iooo had to be applied to Avascularity of a patch of overlying sclera occurred in 27-5 per cent of the patients. These patches often occurred very early in the disease, and the condition must be treated vigorously if further necrosis is to be prevented. The eye was tender in 40 per cent of these patients.
SCLERITIS-DIFFUSE ANTERIOR SCLERITIS
SCLERITIS-NECROTIZING SCLERITIS WITHOUT
ADJACENT INFLAMMATION (SCLEROMALACIA PERFORANS) (Fig. 8) This condition was associated with long-standing rheumatoid arthritis in 46 per cent of patients. They presented without any subjective symptoms, the doctor or the patient having noticed either a greyish or yellowish patch on the sclera or, in more severe cases, areas of complete loss of tissue. Any inflammatory change was minimal. There was no reactive oedema because it appeared that the episcleral tissue overlying the defect had disappeared, and elsewhere it was so thin as to be almost invisible. The number of vessels in the remaining episcleral tissue also appeared to be much diminished, giving a porcelain-like appearance to the white of the eye when viewed from a distance. Altogether 40 per cent of the patients had more than one necrotic patch. We had the opportunity of watching some of these develop and the pattern seemed to be the same. The conjunctiva and remaining episclera might become suffused over a wide area or might remain unaltered. A demarcation line would develop in the sclera, like a circular crack, and the area inside this would take on a yellowish or greyish appearance and after a variable period would separate as a sequestrum together with the overlying episciera. Large abnormal vessels surrounded and crossed the area, and where they crossed it near the limbus they left an area of about o 5 mm on either side of a relatively normal sclera. The resulting defect was covered by a very thin layer of connective tissue which appeared to be derived from the conjunctiva. Unless the intraocular pressure rose, no staphyloma was seen. In no case was the eve tender to the touch.
SCLERITIS-POSTERIOR SCLERITIS
We were certain of the diagnosis in six cases (2z9 per cent), but it was suspected in several cases, and it was likely that others escaped our notice. Since there are no apparent external signs of posterior scleritis unless there is also an associated anterior scleritis, the presence of proptosis, exudative detachment and other fundus changes, including papilloedema, may mislead the ophthalmologist to such an extent that the correct diagnosis is never made. In view of this it is possible that the incidence of posterior scleritis may not be as low as indicated by the present series, as our patients were all referred from elsewhere. The condition was unilateral in four of the six cases. Table V. Acute stromal keratitis (Fig. I3) In the severe necrotizing scleritis of acute onset the cornea became oedematous and dense white infiltrates appeared within the stroma (Fig. I3 (Fig. I5 ).
Keratolysis
The most severe corneal disease of all is keratolysis. This was seen in only four patients, all of whom had very severe necrotizing scleritis, usually, but not invariably, accompanied by loss of scleral tissue. In this terrifying situation the whole stroma of the cornea disappeared with alarming rapidity (Fig. i6) . The Watson, I974) , which presented as an interstitial keratitis indistinguishable from that seen in congenital syphilis but which occurred in patients who had a mild scleritis and in whom the serological investigations were entirely negative (Fig. 17) .
Keratitis could be considered the sole reason for a severe fall in visual acuity in I3 eyes (4 per cent).
EPISCLERITIS
Minimal corneal changes were seen in i5 per cent of the patients with simple episcleritis and in 15 per cent of those with nodular disease, but these were never severe. The oedema of the cornea occurred when the episcleral inflammation was close to the limbus and seemed to be a consequence of this adjacent inflammation. Keratitis was most common in the superficial and midstromal layers of the cornea in both varieties. Some localized corneal guttering occurred in six eyes after recurrent attacks in the same area for many months.
Vascularization of the cornea occurred in six eyes, the vessels being deep in three, midstromal in one, Posterior uveitis All the patients with posterior scleritis had posterior uveitis, but posterior uveitis was also found in those who had an anterior scleritis (Table VIII) .
In two of the patients with nodular anterior scleritis, and in three of those with necrotizing disease, discrete areas of subretinal exudation Of the patients with secondary glaucoma nine had no abnormality other than scleritis, seven also had keratitis, and six uveitis.
Secondary glaucoma often accompanies severe anterior scleritis, the cause apparently being due to obstruction of the outflow channels by oedema because the intraocular pressure falls and the outflow of aqueous rises as soon as the scleritis comes under control with systemic treatment. Six patients, who had anterior synechiae and a long-standing uveitis with secondary glaucoma, required other medication for control of the intraocular pressure. None of these patients has yet required surgery.
No patient with posterior scleritis had glaucoma. One patient developed a steroid glaucoma which has required continuous medication for its control.
Glaucoma was detected in nine eyes (4 per cent).
Two patients were known to have chronic openangle glaucoma before the onset of the episcleritis. Five eyes had developed a steroid glaucoma from prolonged administration of local steroids. In no instance could the glaucoma be attributed to the episcleral inflammation, although there was corneal involvement in one eye.
Scleral thinning
When the sclera looked blue in the daylight when contrasted with surrounding white sclera this was regarded in our analysis as scleral thinning. The sclera in many of these patients had become transparent rather than thin; however, the blue patch appeared only in cases in which there had been active disease. The change in transparency was usually not apparent during the active stage of the disease but it was observed at the site of recurrent simple or nodular episcleritis in I 9 eyes (8 per cent), and in 36-5 per cent of eyes affected with scleritis, during the period of follow-up.
After repeated attacks of episcleritis, particularly if these occurred at the same site, the sclera might become transparent but not thin. Similarly in diffuse and nodular scleritis the sclera might become transparent with the blue choroid showing through. This was easily seen in daylight and could be used as an indication of previous scleral inflammation. Ectasia and destruction of scleral tissue occurred only in necrotizing scleritis. This could take the form of an avascular area appearing in the centre of an area of scleritis, which then broke down to form a slough and eventually to leave an area of thinning. 
I6
In the type of necrotizing scleritis which progressed around the globe, the area behind the advancing edge could become extremely thin, and sometimes melted away altogether. In the variety of necrotizing scleritis without inflammation (scleromalacia perforans), the episclera was usually extremely thin (Fig. 8) , and the underlying sclera would become white, develop a demarcated margin, and then become sequestrated. The conjunctiva and thin episclera overlying this process might be slightly congested but this was by no means always the case. A combination of A-and B-scan ultrasound could be used to distinguish between thinning and increased transparency-A-scan being used to estimate the thickness and B to locate the lesion.
Scleral defects (Fig. i8 In nodular anterior scleritis seven patients had other diseases-for example, Cogan's syndrome (3), thyrotoxicosis (2), ophthalmia nodosa (I),. (Fig. I9) . All have done well.
Two patients were given scleral grafts to cover thin sclera. The graft remained in place in one; in the other patient the graft became involved by scleritis and eroded away, leaving the choroid covered by a thin layer of conjunctiva. The course of the scleral disease was not influenced by the grafting. Enucleation Scleritis is a serious condition and even if fully and carefully treated can lead to the loss of the eye, as indeed happened in three of the patients in this series. Only one of these patients was seen early in the disease and she was not able to tolerate steroid treatment; the eye was removed for intractable pain after the necrotizing disease had spread inexorably around the globe. The vision was preserved until the last area of undamaged sclera became involved, but then fell rapidly from 6/i8 to hand movements within a week. Another eye was removed because it was blind and extremely painful. The third patient had severe keratolysis and necrotizing scleritis with loss of corneal and scleral tissue when first seen. Attempts at covering these defects by grafting failed and the eye was eventually removed.
Follow-up
Of the 159 patients with episcleritis and the 207 patients with scleritis, 146 (9i per cent) and i86 (go per cent), respectively, have been followed-up during a period of between one and eight years (mean 5-8 years). All the patients who had not attended the clinic for six months and had had the disease for at least one year were sent a questionnaire in an attempt to determine the recurrence rate. Altogether 332 patients, of 366 who were circularized (9I per cent), replied to the questionnaire or returned to the clinic for follow-up.
In cases in which scleritis was seen in the initial stages and fully treated the recurrence rate was only 20 per cent. The recurrence rate was higher in those patients with anterior diffuse scleritis than It is important to follow up those patients with necrotizing disease because the disease can continue to progress when they are symptom-free, and they may require continuous treatment even when the disease is quiescent.
In episcleritis, however, each attack is selflimiting and usually clears without treatment. This has been confirmed in a double-blind controlled trial (Watson and others, 1973) in which each attack varied from a few hours to several days, the average being about seven days. Episcleritis was most common in the interpalpebral region, often changing from one side to the other with each attack. However, some patients always developed the inflammation at the same site although recurrences of both episcleritis and scleritis could occur up to 30 years after the onset of the disease (Table XVII) . Two-thirds of the patients had recurrences up to six years after the onset of the disease, but after this the recurrence rate fell. We found that there was often a considerable interval between the onset of the disease and the first attendance of the patient, who often came only because of apprehension caused by the recurrent attacks rather than the severity of the symptoms.
Deaths (Table XIX) Of the I4 patients who were known to have died during the period of follow-up, only two had episcleritis. One died as a result of a road accident, and the other committed suicide. Of the remaining patients, six (43 per cent) had had necrotizing scleral disease, one diffuse anterior scieritis, and five nodular scleritis. None of the patients with scleromalacia perforans was known to have died during this period, although many of these patients Early diagnosis may lead to early treatment of the general condition, prolonging and probably improving the quality of life for these patients.
In our present series 46 per cent of the patients with scleritis had a known associated systemic condition. Of these, I5 per cent had definite connective-tissue disease, confirmed by a rheumatologist (Table XI) . This incidence has recently been confirmed in an analysis of a further 88 patients with scleritis, in whom the incidence of associated systemic disease was 42 per cent, of which I5 per cent consisted of connective-tissue diseases.
It has been suggested in the literature (DukeElder and Leigh, I965) The aetiology of episcleritis is even more uncertain. However, two patterns are apparent. Most patients have intermittent bouts of moderate or severe inflammation at intervals of one to three months, lasting seven to ten days and occurring much more commonly during the spring and autumn than in the summer or winter. Only rarely can any certain precipitating factor be found, the attacks usually being related to family upsets and worries at work. Occasionally, however, a clear history of exogenous sensitization is given-for example, contact with printer's inks. In one instance the patient had only to be inside the printing works for his eyes to flare up; exposure to the vapours of the ink also produced an attack under hospital conditions, but skin tests gave negative results. i i per cent of patients with episcleritis had recurrently high serum uric acid values (more than 6 5 mg per cent on three readings), and 7 per cent had clinical gout. 12 per cent also had a history of asthma and hay fever; only one patient related the attacks to menstruation. Two patients developed episcleritis after a desensitization vaccination.
The second group of patients gave no history of periodicity but rather of mild, prolonged attacks of inflammation. Into this category came almost all those patients who had some other intercurrent disease. Seven patients had a positive Wassermann reaction (one with active syphilis), four had mild rheumatoid arthritis with a positive rheumatoid factor but only a few joint symptoms, and two had erythema multiforme; the others had active tuberculosis, Henoch-Schonlein purpura, or rosacea. Herpes simplex virus has been grown from one lesion. The appearances of the episcleritis did not differ in these two groups, and in neither did the episcleritis progress to a scleritis except in those patients with herpes zoster who have already been discussed. General physical examination and chest x-ray failed to reveal any evidence of focal sepsis. Whatever the pathogenesis might be, we found that by careful differential diagnosis we were able to treat the disease appropriately and adequately so as to prevent a serious destructive change taking place in the eye. The differential diagnosis of scleritis and episcleritis is summarized in Table XX. TREATMENT Apart from the very few patients in whom a specific bacterial or viral agent could be found to In this trial some patients received placebo, others local steroid ointment, and the remainder oxyphenbutazone ointment. All the patients recovered within I0 days. Both oxyphenbutazone eye ointment and betamethasone ointment appeared to hasten the recovery by about one day, but the differences were not significant (Watson and others, 1973) (Fig. 20) (Hayreh and Watson, I970) . Why this preparation is so effective is uncertain, but we have several patients who have to be maintained on it rather than on the conventional steroids.
Surgery
Surgery is very rarely necessary in scleral disease. Provided the condition is seen early and treated vigorously, scleral necrosis can be largely prevented. Comeal grafting has had to be performed in four patients because of threatened perforation, an expanding globe, for peripheral corneal guttering, and for descemetocele. The corneal grafts have taken well and in all cases the scleritis has become less severe after this was done.
Many reports appear in the literature of scleral grafting for scleromalacia perforans (Holthouse, I893; Ashton and Hobbs, 1952; Torchia, Dunn, Pease, I968; Vancea, Vancea, Jalobceastii, Colev, and Calin, 1971; Sevel and Abramson, 1972; and others) . This has been necessary in only two patients in this series-neither of whom could tolerate steroids. In both patients the graft took well. In one the whole necrotic area was removed and the residual area of scleral inflammation could be controlled with local steroids and oxyphenbutazone systemically. In the other the necrotizing process continued from the edge of the scleral overlap and the eye was eventually lost, no other medical treatment being tolerated.
We consider scleritis to be a medically treatable condition, and provided the dosages of the drugs are adequate to suppress the inflammatory change, the condition will be controlled. In this we disagree with Sevel and Abramson (1972) and Aronson and Elliott (I974). We feel our results justify our claim.
Summary
The data from I59 patients (217 eyes) with episscleritis and 207 patients (30I eyes) with scleritis have been investigated in detail and the results analysed with the help of a computer. Of these patients, 9I per cent were followed-up during a 
